COMPASS Pathways Plc - American Depository Shares (CMPS)

$33.14 0.00 (0.00%)

16:00 EDT CMPS Stock Quote Delayed 30 Minutes

Growing Psychedelic Interest Will Help Push Compass Pathways Stock Up 3X By 2022

By Luke Lango and the InvestorPlace Research Staff Aug 4, 2021

By 2030, psychedelic therapy will be the gold standard for mental health treatment. And Compass is at the forefront of commercialization.

7 Stocks to Buy if You Think Alternative Therapies Are the Future

What Will the Stock Market Do Today? 3 Big Stories to Watch.

3 Psychedelics Stocks Getting High Thanks to the Newly Launched PSY ETF

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.)

Day's Range 33.14 - 33.14

52-Week Range 22.51 - 61.69

Dividend & Yield N/A (N/A)

CMPS Stock Predictions, Articles, and COMPASS Pathways Plc - American Depository Shares News

From InvestorPlace
From the Web

Compass Pathways Offers Chance on Exploratory Mental Health Treatments

By David Moadel, InvestorPlace Contributor May 18, 2021

Over the past year, CMPS stock has been going nowhere fast. However, there's been recent progress in advancing psilocybin-assisted therapy.

What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.

By Sarah Smith, Editor, Today's Market May 17, 2021

So what did the stock market do today? All eyes were on Bitcoin prices, EV stocks and hype in the psychedelics market.

3 Top Psychedelic Stocks to Own Now

By Ian Cooper May 6, 2021

Psychedelics could be a game-changer for millions struggling with mental health. Here are some of the top ways to trade psychedelic stocks.

MNMD Stock: A MindMed Buzz Kill as the Psychedelic Shares Tank on First Day of Trading

By William White, InvestorPlace Writer Apr 27, 2021

MindMed (MNMD) stock isn't doing so hot with shares taking a beating on the first day of trading at their new home on the Nasdaq.

What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.

By Sarah Smith, Editor, Today's Market Apr 26, 2021

So what did the stock market do today? All eyes were on Tesla stock as it set a new record and MNMD stock ahead of its listing.

The Shroom Boom Is Here. Buy CMPS Stock to Ride This Explosive Megatrend.

By Luke Lango, InvestorPlace Senior Investment Analyst Apr 26, 2021

IPOs. Uplistings. Academic studies. All the stars are aligning for "shroom stocks", so it's time to buy CMPS stock on the dip.

3 of the Top Psychedelic Stocks That Will Blow Your Mind

By Muslim Farooque Apr 20, 2021

These psychedelic stocks are the sector's needle-movers and have the potential to make a big splash this year

7 Healthcare Stocks to Buy and Hold for the Long Term

By Faisal Humayun Mar 12, 2021

These steady, strong healthcare stocks are great picks for investors to buy and hold onto for at least the next five years.

5 Groovy Psychedelic Stocks to Buy

By Ian Cooper Jan 8, 2021

Psychedelic stocks could have another “far out” year ahead with U.S. FDA support, as well as more clinical trials that are under way.

3 Psychedelic Stocks Taking Mental Health Seriously

By Faisal Humayun Dec 30, 2020

These psychedelic stocks are worth accumulating on corrections. The companies are holding clinical trials for mental health drugs.

Find Your Next 10X Winner in the Burgeoning Shroom Boom

By Luke Lango, InvestorPlace Senior Investment Analyst Dec 3, 2020

Psychedelic stocks are going to surge as the once "hardcore" group of pschedelic drugs gains widespread mainstream medicinal acceptance.

4 Megatrends the Election Has Kicked Into Hyperdrive

By Luke Lango, InvestorPlace Senior Investment Analyst Dec 3, 2020

These four megatrends are in high gear after the 2020 Presidential election. These are the best stocks to buy now.

Trade the Burgeoning ‘Shroom Boom’ with COMPASS Pathways Stock

By David Moadel, InvestorPlace Contributor Nov 12, 2020

Could psilocybin therapy become a hyper-growth market in mental health medicine? It could happen, so consider a position in CMPS stock.

Thanks to the Shroom Boom, This Small Stock Could Soar

By Luke Lango, InvestorPlace Senior Investment Analyst Oct 13, 2020

In mid-September, the true leader of the Shroom Boom -- COMPASS Pathways (NASDAQ:CMPS) -- finally came public via an IPO that was a huge success.

Compass Pathways IPO: 5 Things for Potential CMPS Investors to Know

By Sarah Smith, Editor, Today's Market Sep 21, 2020

CMPS stock shot up more than 70% during its first trading. Here is what else investors need to know about the recent Compass Pathways IPO.

Which Psychedelic Stock ETF Is Right For You?

From Talk Markets Sep 18, 2021

This week the AdvisorShares Psychedelics ETF began trading on the NYSE Arca. Here we compare the make-up of the now 3 psychedelic stock ETFs and two tracking indexes.

Compass: Psychedelics Unicorn Expands Portfolio Beyond Psilocybin Into Psychedelics 2.0

From Benzinga Sep 15, 2021

Psychedelics biotech company Compass Pathways (NASDAQ:CMPS...

Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry?

From Benzinga Sep 9, 2021

By Natan Ponieman and Javier Hasse The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate...

3 Psychedelic Stocks Wall Street Predicts Will Double or Triple

From StockNews.com Sep 9, 2021

The psychedelic industry has attracted unprecedented attention amid the COVID-19 pandemic due to the increasing acceptance of psychedelic treatments for mental health. Because the demand for psychedelic products is expected to increase, we think it could be wise to add popular stocks in this space COMPASS Pathways (CMPS), Mind Medicine (MNMD), and Seelos Therapeutics (SEEL) to one’s watchlist. Wall Street analysts expect these stocks to double or triple in price in the coming months. So, let’s discuss these names.

Magic Mushroom Drug Stock Performances YTD

From Talk Markets Aug 29, 2021

Of the 35 companies involved in clinical stage research of psychedelic substances, 20 are researching the benefits of psilocybin, the primary psychoactive ingredient in “magic mushrooms”.

Braxia Scientific Launches Broad Criteria Trial On Psilocybin For Depression

From Benzinga Aug 27, 2021

Braxia Scientific Corp. (CSE:BRAX) (OTC:

PICKS & PANS

COMPASS Pathways Plc - American Depository Shares (CMPS)

Growing Psychedelic Interest Will Help Push Compass Pathways Stock Up 3X By 2022

7 Stocks to Buy if You Think Alternative Therapies Are the Future

What Will the Stock Market Do Today? 3 Big Stories to Watch.

3 Psychedelics Stocks Getting High Thanks to the Newly Launched PSY ETF

Louis Navellier's Top 6 Stocks for 2021

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

PICKS & PANS

COMPASS Pathways Plc - American Depository Shares (CMPS)

Louis Navellier's Top 6 Stocks for 2021

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

CMPS Stock Predictions, Articles, and COMPASS Pathways Plc - American Depository Shares News

Subscriber Sign in